https://doi.org/10.55788/77b3543c
Dr Andreas Liliequist (Karolinska University Hospital, Sweden) and colleagues conducted a nationwide, case-control study, evaluating the occurrence of arrhythmias in patients with severe COVID-19 who required mechanical ventilation and were discharged from the hospital [1]. The study included 3,023 patients with severe COVID-19 who were treated with mechanical ventilation and 28,463 matched control participants. The primary outcome was hospitalisation for arrhythmia.
After a mean follow-up of 12 months and adjustment for covariates, the risks for ventricular tachycardia (HR 16.3; 95% CI 7.9–33.9), atrial fibrillation (HR 12.6), other tachyarrhythmias (HR 13.9), and bradycardia or pacemaker implantation (HR 8.6) were strongly increased in the COVID-19 group compared with the matched controls. According to the authors, these results imply that patients who were discharged from the hospital after mechanical ventilation for severe COVID-19 and have inherent risk factors for developing arrhythmias should be monitored closely.
- Liliequist A, et al. Surviving critical COVID-19 requiring mechanical ventilation is associated with a high long-term risk of de novo arrhythmic events. ePoster session 49, EHRA 2023, 16–18 April, Barcelona, Spain.
Copyright ©2023 Medicom Medical Publishers
Posted on
Previous Article
« All eyes on Ovarian Cancer: 8 May Next Article
Epicardial ablation successful in Brugada syndrome »
« All eyes on Ovarian Cancer: 8 May Next Article
Epicardial ablation successful in Brugada syndrome »
Table of Contents: EHRA 2023
Featured articles
CEASE-AF meets primary endpoint in persistent AF
ANTWERP score selects HF patients for AF ablation
Ablation for Atrial Fibrillation
Surgery saves lives in patients with oesophageal fistula
MANIFEST-PF: Good results for the pentaspline PFA catheter
POWER FAST III: High-power, short-duration radiofrequency ablation for AF
High-power, short-duration ablation linked to a higher stroke risk
Early or delayed ablation for AF?
CEASE-AF meets primary endpoint in persistent AF
Promising results for Marshall Plan ablation strategy
Updates on Devices
Can ICD-EG-derived information improve ventricular tachycardia ablation outcomes?
Prolonged ECG monitoring detects relevant arrhythmias in HCM
Does adaptive pacing work in patients with HF, LBBB, and intact AV conduction?
Can we identify patients who may not benefit from ICD therapy?
Miscellaneous
Statins display benefits for AF patients in a large population-based study
ANTWERP score selects HF patients for AF ablation
Epicardial ablation successful in Brugada syndrome
Highly increased risk of arrhythmias after mechanical ventilation for COVID-19
Related Articles
January 14, 2022
COVID-19 mRNA vaccination benefits outweigh the risk for myocarditis
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com